AP535A - Indoline derivatives, method of preparation and use. - Google Patents
Indoline derivatives, method of preparation and use. Download PDFInfo
- Publication number
- AP535A AP535A APAP/P/1994/000706A AP9400706A AP535A AP 535 A AP535 A AP 535A AP 9400706 A AP9400706 A AP 9400706A AP 535 A AP535 A AP 535A
- Authority
- AP
- ARIPO
- Prior art keywords
- formula
- compound
- compounds
- pharmaceutically acceptable
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939326192A GB9326192D0 (en) | 1993-12-22 | 1993-12-22 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9400706A0 AP9400706A0 (en) | 1995-01-31 |
| AP535A true AP535A (en) | 1996-09-16 |
Family
ID=10747030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1994/000706A AP535A (en) | 1993-12-22 | 1994-12-20 | Indoline derivatives, method of preparation and use. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5633276A (es) |
| EP (1) | EP0736028A1 (es) |
| JP (1) | JPH09507057A (es) |
| AP (1) | AP535A (es) |
| AU (1) | AU684877B2 (es) |
| CA (1) | CA2179402A1 (es) |
| CO (1) | CO4340623A1 (es) |
| GB (1) | GB9326192D0 (es) |
| IL (1) | IL112097A (es) |
| IS (1) | IS4244A (es) |
| MY (1) | MY131641A (es) |
| SV (1) | SV1994000083A (es) |
| TW (1) | TW291479B (es) |
| WO (1) | WO1995017405A1 (es) |
| ZA (1) | ZA9410056B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741799B1 (fr) * | 1995-12-04 | 1998-01-02 | Oreal | Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue |
| EP1199304A1 (en) * | 1997-03-05 | 2002-04-24 | Takeda Chemical Industries, Ltd. | Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
| US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| HU224220B1 (hu) * | 1996-03-08 | 2005-06-28 | Takeda Pharmaceutical Company Limited | Triciklusos vegyületek, eljárás előállításukra és alkalmazásuk |
| IL129999A (en) * | 1996-12-10 | 2004-06-20 | Bristol Myers Squibb Co | Melatonergic agents which are benzodioxole, benzopuran, dihydrobenzopuran and benzodioxane |
| WO1998038991A1 (en) * | 1997-03-05 | 1998-09-11 | Bristol-Myers Squibb Company | Polycyclic ethyl alkylamide melatonergic agents |
| FR2763335B1 (fr) * | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU727654B2 (en) * | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| WO1999062515A1 (en) | 1998-06-05 | 1999-12-09 | Bristol-Myers Squibb Company | Heterocyclic cis cyclopropane derivatives as melatonergic agents |
| US6211225B1 (en) | 1999-06-30 | 2001-04-03 | Bristol-Meyers Squibb | Heterocyclic aminopyrrolidine derivatives as melatonergic agents |
| GB9918965D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
| ATE293628T1 (de) | 1999-08-20 | 2005-05-15 | Takeda Pharmaceutical | Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel |
| EP1268482B1 (en) * | 2000-03-17 | 2003-09-24 | Alcon, Inc. | Pyranoindoles for treating glaucoma |
| US7012090B1 (en) | 2000-03-17 | 2006-03-14 | Alcon, Inc. | Pyranoindoles for treating glaucoma |
| ES2172415B2 (es) | 2000-07-28 | 2003-11-16 | Univ Madrid Complutense | Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina. |
| WO2002055020A2 (en) * | 2000-12-11 | 2002-07-18 | Testocreme Llc | Topical testosterone formulations and associated methods |
| WO2002079153A1 (en) * | 2001-03-28 | 2002-10-10 | Biocatalytics, Inc. | Method for producing tryptamine derivatives |
| TW200803837A (en) * | 2006-03-20 | 2008-01-16 | Takeda Pharmaceutical | Prophylactic or therapeutic agent for irritable bowel syndrome |
| CN101605795A (zh) | 2006-12-08 | 2009-12-16 | 武田药品工业株式会社 | 三环化合物及其药物用途 |
| ES2331274B1 (es) * | 2007-10-25 | 2010-10-21 | Ferrer Internacional, S.A. | Compuesto de indolina. |
| AU2009275918A1 (en) | 2008-07-30 | 2010-02-04 | Ferrer Internacional S. A. | 1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds |
| BR102016024814A2 (pt) | 2016-10-24 | 2018-05-08 | Aché Laboratórios Farmacêuticos S.A. | composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0043752A1 (fr) * | 1980-06-26 | 1982-01-13 | SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: | Dérivé de pyranno-indole et son procédé de préparation |
| EP0207605A1 (en) * | 1985-05-21 | 1987-01-07 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4738972A (en) * | 1985-05-21 | 1988-04-19 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
-
1993
- 1993-12-22 GB GB939326192A patent/GB9326192D0/en active Pending
-
1994
- 1994-12-08 TW TW083111439A patent/TW291479B/zh active
- 1994-12-16 IS IS4244A patent/IS4244A/is unknown
- 1994-12-19 MY MYPI94003410A patent/MY131641A/en unknown
- 1994-12-19 ZA ZA9410056A patent/ZA9410056B/xx unknown
- 1994-12-20 WO PCT/EP1994/004220 patent/WO1995017405A1/en not_active Application Discontinuation
- 1994-12-20 US US08/652,460 patent/US5633276A/en not_active Expired - Fee Related
- 1994-12-20 CA CA002179402A patent/CA2179402A1/en not_active Abandoned
- 1994-12-20 AU AU12743/95A patent/AU684877B2/en not_active Ceased
- 1994-12-20 AP APAP/P/1994/000706A patent/AP535A/en active
- 1994-12-20 JP JP7517174A patent/JPH09507057A/ja active Pending
- 1994-12-20 EP EP95903817A patent/EP0736028A1/en not_active Ceased
- 1994-12-21 SV SV1994000083A patent/SV1994000083A/es unknown
- 1994-12-21 IL IL112097A patent/IL112097A/en not_active IP Right Cessation
- 1994-12-21 CO CO94057739A patent/CO4340623A1/es unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0043752A1 (fr) * | 1980-06-26 | 1982-01-13 | SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: | Dérivé de pyranno-indole et son procédé de préparation |
| EP0207605A1 (en) * | 1985-05-21 | 1987-01-07 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1274395A (en) | 1995-07-10 |
| IS4244A (is) | 1995-06-23 |
| US5633276A (en) | 1997-05-27 |
| GB9326192D0 (en) | 1994-02-23 |
| EP0736028A1 (en) | 1996-10-09 |
| TW291479B (es) | 1996-11-21 |
| JPH09507057A (ja) | 1997-07-15 |
| ZA9410056B (en) | 1995-10-18 |
| IL112097A0 (en) | 1995-03-15 |
| SV1994000083A (es) | 1995-07-24 |
| AU684877B2 (en) | 1998-01-08 |
| CO4340623A1 (es) | 1996-07-30 |
| WO1995017405A1 (en) | 1995-06-29 |
| CA2179402A1 (en) | 1995-06-29 |
| AP9400706A0 (en) | 1995-01-31 |
| IL112097A (en) | 1998-06-15 |
| MY131641A (en) | 2007-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP535A (en) | Indoline derivatives, method of preparation and use. | |
| JP2941309B2 (ja) | 化合物 | |
| JP5271903B2 (ja) | オピオイド受容体系に作用する、４−ヘテロアリール置換された１−アミノシクロヘキサン−１−及びシクロヘキセン−１−誘導体 | |
| RU2095360C1 (ru) | Производные индола, их оптические изомеры и фармацевтически приемлемые соли | |
| JP3033076B2 (ja) | カンナビノイド受容体への親和性を有するインドール誘導体 | |
| KR930003759B1 (ko) | 인돌 유도체의 제조방법 | |
| US5981572A (en) | Benzofurans and benzopyrans as chronobiological agents | |
| LU85743A1 (fr) | Composes heterocycliques | |
| JPH06199784A (ja) | 新規なアリールエチアミン化合物、その製法、及びこれを含有する医薬組成物。 | |
| JPS6277383A (ja) | 複素環式化合物 | |
| JPH10508297A (ja) | ニューロキニンアンタゴニストとしての置換アリールピペラジン | |
| JP2000510153A (ja) | スピロ―ピペリジン誘導体及び該誘導体の治療薬としての使用 | |
| JPH08506823A (ja) | アザ環式化合物、該化合物を含む組成物及びタキキニン拮抗剤としての該化合物の使用 | |
| JP2001521925A (ja) | Ｐｄｅ４阻害剤におけるカテコールのインダゾールバイオイソステル置換に基づく治療学的に活性な化合物 | |
| US7060710B2 (en) | Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands | |
| JPH08512299A (ja) | ５ｈｔ▲下２ｃ▼アンタゴニストとしてのインドリン誘導体 | |
| JPH10502336A (ja) | ナフタレン誘導体、製造方法および使用 | |
| CH667454A5 (fr) | Derives d'indoles. | |
| US20030073832A1 (en) | Novel aminophenyl ketone derivatives | |
| JP2001504501A (ja) | ５−ｈｔ▲下１ｄ▼レセプターのリガンドとしての５−シクロインドール化合物 | |
| JPH05262766A (ja) | ピペリジルメチル−置換クロマン誘導体 | |
| JP2941333B2 (ja) | インドール誘導体 | |
| JP2791069B2 (ja) | シクロオクタン神経保護剤 | |
| JPH06505698A (ja) | 新規化合物 | |
| JPH09512034A (ja) | ５ｈｔ１−様作動薬としてのインドール誘導体 |